Global Primary Cell Culture Market by Application (Vaccine Production, Virology), by Product (Media, Reagents & Supplements) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global primary cell culture market was valued at USD 3.34 billion in 2020. It is projected to grow at a compound annual rate of 11.6% between 2021 and 2028. Market growth is primarily due to an increase in chronic conditions such as cancer, infections and diabetes mellitus. This has facilitated the adoption of primary cells cultures, which has resulted in an increase in research.
According to the American Cancer Society (2020), there will be 16.9 million survivors/patients of cancer. According to WHO (2020), 71.0 millions people are living with chronic hepatitis C. The rising prevalence of chronic diseases is driving demand for advanced treatments, which will drive market growth over the next few years.
The market for primary cells culture can also be attributed to an increase in the use of primary cell cultures for drug screening and in-vitro testing. They are derived from tissue, which allows researchers to examine cellular structure and normal functioning in the in-vivo state. They are therefore used to study cell biochemistry, physiology, signaling studies, metabolic processes, and the effects of toxic compounds and drug.
The COVID-19 pandemic has been a positive catalyst to the expansion of primary cell culture markets. Primary cell culture is increasingly being used by researchers to understand the infection. The use of standardized and characterized epithelium cell-culture models is helping to understand the physical barrier that was destroyed by the coronavirus. These models are able to mimic the functions and properties in the respiratory tract. This can lead to medical applications.
The primary immune cell culture was also proven to be extremely beneficial in the study and production of antibodies and antigens by the COVID-19virus. The German Primate Center in Gottingen has found that the COVID-19 virus can block infection of lung cells by using TMPRSS2, which is an inhibitor for serine protease. These results were confirmed by the primary cell culture experiment.
Product Insights
In 2020, the largest share of revenue was 34.0% for the reagents & supplements segment in the primary cell culture market. This segment has seen a steady increase in sales due to its regular use in primary cell culture research and manufacturing. Primary cells are fragile and require reagents or supplements to grow.
The segment is also being impacted by the creation of new products like growth factors and cytokines. In October 2020, iBio, Inc., a U.S-based biotechnology company, entered into a strategic agreement for the development growth factors and cytokines with Safi Biosolutions, Inc.
Over the forecast period, the primary cells segment will experience the fastest CAGR at 11.8%. This is due to the increasing number of primary cells that can be used for different diseases. In February 2021, Garvan Institute of Medical Research researchers discovered a new bone cell type which could lead to new therapeutic targets for osteoporosis. These robust research efforts are expected to greatly boost the growth of the segment.
Separation Methods Research
Enzymatic degradation was the dominant segment in the primary cell culture market and had a 33.3% revenue share in 2020. This segment holds a large market share due to its preference over other methods for separating primary cells. It has the following advantages: less damage to cultures; comparatively fast; high yield of representative samples.
Trypsin was the dominant market leader in primary cell culture revenue in 2020, owing to its high use for enzyme disaggregation. This enzyme is widely used for the dissociation and processing of adhesive cells in flasks and rapid passage of large cell suspension.
Due to technological advances in mechanical separation, the segment of mechanical separation is expected to see a profitable CAGR of 11.7% during the forecast period. In October 2020, researchers from France used mechanical extraction and immuno-magnetic cell sorting to culture primary skin cells taken from patients with systemic sclerosis. This technique was found to have a higher purity rate than conventional methods for human dermal microvascular cells.
Application Insights
In 2020, the vaccine production segment held 12.2% of the total revenue. It dominated the primary cell culture market. This is due to an increasing use of primary animal culture for virus production, which is later used for several vaccines like measles and hepatitis B. This has resulted in a cost reduction due to the use of animal models as vaccine testing.
Over the forecast period, the stem cell therapy market is expected to grow at a profitable CAGR of 11.9%. This segment has seen a lot of interest from scientists around the globe to conduct various research projects using cells. Researchers are changing the way they perceive primary cells through research using adult, embryonic and induced stem cells. Stem cell-based therapies also have great potential and are being used in neurodegenerative diseases and other conditions such as diabetes, eye diseases, retinal diseases, and dentistry. Market growth is expected to continue as these therapies are increasingly used.
Cell Type Insights
Animal cells dominated the primary cell culture market and was responsible for 58.6% of the total revenue in 2020. The segment's growth is largely due to the increasing use of primary cells from animals for vaccine development. For the development of vaccines against measles and rabies, as well as chickenpox and hepatitis B, primary cultures derived from animals have been used.
Segment growth can also be attributed to the large product range of animal-origin prima cells offered by companies like Lonza, Merck KGaA, and Thermo Fisher Scientific, Inc. These include hepatocytes, hepatocytes, keratinocytes, immune, hematopoietic and mesangial stem cells, as well as rat, monkey, and mouse-derived fibroblasts.
Over the forecast period, significant growth is expected in the human cells segment. This is mainly due to the increasing use of human-derived primaries cultures for cancer research. Primary human cancer cells can be derived from many tissue types, including brain, muscle, connective tissue, to allow for the physiologically relevant study on cancer. These cultures are able to be used for clinical and preclinical analyses as well as clinical studies in the field of cancer research.
Regional Insights
North America was the dominant market for primary cell culture and held 52.6% of the total revenue share in 2020. This trend is expected to continue over the forecast period. This region's growth can be attributed in part to its high healthcare spending, increasing geriatric population, rising prevalence of chronic diseases, and support from government funding. Market growth is also being driven by the increased focus of market players on innovating cell culture applications, instrumentation and the availability of various types of cells as well as their cellular interactions.
Asia Pacific will be the fastest growing region during the forecast period. This is due to the low cost of stem cell transplantation in this region, which has contributed to the high demand. Research is also ongoing, which can further be attributed to the region’s growth. In March 2020, for example, the Centre for Disease Control in China (CDC) grew lung cells using human tissue culture systems to spread SARS-CoV-2.
Market Share Insights & Key Companies
These companies are developing new products for primary cell cultivation. Thermo Fisher Scientific Inc., for example, launched a new medium to expand human T lymphocytes in January 2021 for allogeneic cell therapy. The new Gibco CTS OpTmizer PRO SFM aids in increasing donor T (lymphocyte cell) proliferation. This media solution is designed to target the metabolism of healthy donors and produce cost-effective cell therapies. The following are some of the major players in the primary cell-culture market:
-
Thermo Fisher Scientific, Inc.
-
Lonza
-
Merck
-
Corning Incorporated
-
Danaher
-
PromoCell GmbH
-
ATCC
-
FUJIFILM Irvine Scientific, Inc.
-
Mattek
-
Axol Bioscience Ltd.
Up Market Research published a new report titled “Primary Cell Culture Market research report which is segmented by Application (Vaccine Production, Virology), by Product (Media, Reagents & Supplements), By Players/Companies Merck, Mattek, FUJIFILM Irvine Scientific Inc, PromoCell GmbH, Lonza, Thermo Fisher Scientific Inc, Axol Bioscience Ltd, Danaher  , ATCC, Corning Incorporated”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Primary Cell Culture Market Research Report |
| By Application | Vaccine Production, Virology |
| By Product | Media, Reagents & Supplements |
| By Companies | Merck, Mattek, FUJIFILM Irvine Scientific Inc, PromoCell GmbH, Lonza, Thermo Fisher Scientific Inc, Axol Bioscience Ltd, Danaher  , ATCC, Corning Incorporated |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 209 |
| Number of Tables & Figures | 147 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Primary Cell Culture Market Report Segments:
The market is segmented by Application (Vaccine Production, Virology), by Product (Media, Reagents & Supplements).
Primary Cell Culture Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Primary Cell Culture Market
Overview of the regional outlook of the Primary Cell Culture Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Primary Cell Culture Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Primary Cell Culture Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Vaccine Production
2. Virology
7. By Product:1. Media
2. Reagents & Supplements
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Primary Cell Culture Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Primary Cell Culture Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Primary Cell Culture Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Primary Cell Culture Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Primary Cell Culture Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Primary Cell Culture Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Primary Cell Culture Market Size & Forecast, 2018-2028
4.5.1 Primary Cell Culture Market Size and Y-o-Y Growth
4.5.2 Primary Cell Culture Market Absolute $ Opportunity
Chapter 5 Global Primary Cell Culture Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Primary Cell Culture Market Size Forecast by Application
5.2.1 Vaccine Production
5.2.2 Virology
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Primary Cell Culture Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Primary Cell Culture Market Size Forecast by Product
6.2.1 Media
6.2.2 Reagents & Supplements
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Primary Cell Culture Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Primary Cell Culture Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Primary Cell Culture Analysis and Forecast
9.1 Introduction
9.2 North America Primary Cell Culture Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Primary Cell Culture Market Size Forecast by Application
9.6.1 Vaccine Production
9.6.2 Virology
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Primary Cell Culture Market Size Forecast by Product
9.10.1 Media
9.10.2 Reagents & Supplements
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Primary Cell Culture Analysis and Forecast
10.1 Introduction
10.2 Europe Primary Cell Culture Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Primary Cell Culture Market Size Forecast by Application
10.6.1 Vaccine Production
10.6.2 Virology
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Primary Cell Culture Market Size Forecast by Product
10.10.1 Media
10.10.2 Reagents & Supplements
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Primary Cell Culture Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Primary Cell Culture Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Primary Cell Culture Market Size Forecast by Application
11.6.1 Vaccine Production
11.6.2 Virology
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Primary Cell Culture Market Size Forecast by Product
11.10.1 Media
11.10.2 Reagents & Supplements
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Primary Cell Culture Analysis and Forecast
12.1 Introduction
12.2 Latin America Primary Cell Culture Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Primary Cell Culture Market Size Forecast by Application
12.6.1 Vaccine Production
12.6.2 Virology
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Primary Cell Culture Market Size Forecast by Product
12.10.1 Media
12.10.2 Reagents & Supplements
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Primary Cell Culture Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Application
13.6.1 Vaccine Production
13.6.2 Virology
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Product
13.10.1 Media
13.10.2 Reagents & Supplements
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Primary Cell Culture Market: Competitive Dashboard
14.2 Global Primary Cell Culture Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Mattek
14.3.3 FUJIFILM Irvine Scientific Inc
14.3.4 PromoCell GmbH
14.3.5 Lonza
14.3.6 Thermo Fisher Scientific Inc
14.3.7 Axol Bioscience Ltd
14.3.8 Danaher Â
14.3.9 ATCC
14.3.10 Corning Incorporated
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Primary Cell Culture Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Primary Cell Culture Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Primary Cell Culture Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Primary Cell Culture Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Primary Cell Culture Market Size & Forecast, 2018-2028
4.5.1 Primary Cell Culture Market Size and Y-o-Y Growth
4.5.2 Primary Cell Culture Market Absolute $ Opportunity
Chapter 5 Global Primary Cell Culture Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Primary Cell Culture Market Size Forecast by Application
5.2.1 Vaccine Production
5.2.2 Virology
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Primary Cell Culture Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Primary Cell Culture Market Size Forecast by Product
6.2.1 Media
6.2.2 Reagents & Supplements
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Primary Cell Culture Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Primary Cell Culture Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Primary Cell Culture Analysis and Forecast
9.1 Introduction
9.2 North America Primary Cell Culture Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Primary Cell Culture Market Size Forecast by Application
9.6.1 Vaccine Production
9.6.2 Virology
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Primary Cell Culture Market Size Forecast by Product
9.10.1 Media
9.10.2 Reagents & Supplements
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Primary Cell Culture Analysis and Forecast
10.1 Introduction
10.2 Europe Primary Cell Culture Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Primary Cell Culture Market Size Forecast by Application
10.6.1 Vaccine Production
10.6.2 Virology
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Primary Cell Culture Market Size Forecast by Product
10.10.1 Media
10.10.2 Reagents & Supplements
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Primary Cell Culture Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Primary Cell Culture Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Primary Cell Culture Market Size Forecast by Application
11.6.1 Vaccine Production
11.6.2 Virology
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Primary Cell Culture Market Size Forecast by Product
11.10.1 Media
11.10.2 Reagents & Supplements
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Primary Cell Culture Analysis and Forecast
12.1 Introduction
12.2 Latin America Primary Cell Culture Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Primary Cell Culture Market Size Forecast by Application
12.6.1 Vaccine Production
12.6.2 Virology
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Primary Cell Culture Market Size Forecast by Product
12.10.1 Media
12.10.2 Reagents & Supplements
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Primary Cell Culture Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Application
13.6.1 Vaccine Production
13.6.2 Virology
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Primary Cell Culture Market Size Forecast by Product
13.10.1 Media
13.10.2 Reagents & Supplements
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Primary Cell Culture Market: Competitive Dashboard
14.2 Global Primary Cell Culture Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Mattek
14.3.3 FUJIFILM Irvine Scientific Inc
14.3.4 PromoCell GmbH
14.3.5 Lonza
14.3.6 Thermo Fisher Scientific Inc
14.3.7 Axol Bioscience Ltd
14.3.8 Danaher Â
14.3.9 ATCC
14.3.10 Corning Incorporated
Segments Covered in the Report
The global Primary Cell Culture market has been segmented based on
By Application
The global Primary Cell Culture market has been segmented based on
By Application
- Vaccine Production
- Virology
- Media
- Reagents & Supplements
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Merck
- Mattek
- FUJIFILM Irvine Scientific Inc
- PromoCell GmbH
- Lonza
- Thermo Fisher Scientific Inc
- Axol Bioscience Ltd
- Danaher Â
- ATCC
- Corning Incorporated
Our Clients
Related Reports
Some other reports from this category!
